Ernst Boehnlein

Title: The Innovations of Ernst Boehnlein

Introduction

Ernst Boehnlein is a notable inventor based in Langenfeld, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of microproteins. His work has implications for pharmaceutical applications and medical treatments.

Latest Patents

Ernst Boehnlein holds a patent for "Dimeric or multimeric microproteins." This patent discloses a polypeptide comprising at least two microproteins, which preferably include an amino acid sequence that exhibits specific binding activity to a target protein. The patent also covers polynucleotides encoding such polypeptides, as well as pharmaceutical compositions and kits that incorporate these polypeptides or polynucleotides. Additionally, the patent outlines methods of treatment and second medical uses involving the disclosed polypeptides or polynucleotides. Furthermore, it describes a method for forming a covalent bond in a microprotein, which can be utilized for producing the disclosed polypeptides.

Career Highlights

Ernst Boehnlein is associated with BioNTech AG, a leading biotechnology company known for its innovative approaches to vaccine development and cancer therapies. His work at BioNTech AG has positioned him at the forefront of biopharmaceutical research.

Collaborations

Throughout his career, Ernst Boehnlein has collaborated with esteemed colleagues such as Harald Kolmar and Hans-Ulrich Schmoldt. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Ernst Boehnlein's contributions to the field of biotechnology, particularly through his patent on microproteins, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and pharmaceutical applications.